EFFECTS OF GLUTAMINE ON INFECTIOUS COMPLICATIONS AND MORTALITY IN CRITICAL ILLNESS
Enteral Glutamine Supplementation
There are few high-quality trials investigating the clinical benefit of enteral glutamine supplementation. In one small study, burn patients receiving enteral glutamine supplementation had a significant decrease in mortality compared with patients who did not receive supplementation (Garrel et al. 2003). However, in the largest study of a heterogeneous group of 363 Australian ICU patients receiving enteral nutrition supplemented with either glutamine or glycine (Hall et al. 2003), glutamine supplementation had no effect on 6-month mortality or incidence of severe sepsis. When data from 8 trials examining the effect of glutamine-supplemented enteral nutrition in critically ill patients were pooled in a meta-analysis, there was no overall difference in mortality (RR = 0.81, 95% confidence interval 0.48-1.34) or infectious complications (RR = 0.83, 95% confidence interval 0.64-1.08) between groups who received glutamine and those who did not (Composition of Enteral Nutrition: Glutamine 2013). As a result, there is insufficient evidence to recommend routine use of enteral glutamine in critically ill patients (Composition of Enteral Nutrition: Glutamine 2013).